# Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)

> **NCT00160407** · PHASE4 · COMPLETED · sponsor: **St. Louis University** · enrollment: 50 (—)

## Conditions studied

- Fatty Liver
- Hepatitis

## Interventions

- **DRUG:** Orlistat (Xenical)
- **BEHAVIORAL:** 1400 kcal diet (30% fat)

## Key facts

- **NCT ID:** NCT00160407
- **Lead sponsor:** St. Louis University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 50 (—)
- **Last updated:** 2007-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00160407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00160407, "Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00160407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*